Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 701-463-8 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 August 2014 - 06 March 2015
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed according to OECD test guideline No. 471 and in compliance with GLP.
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 015
- Report date:
- 2015
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Version / remarks:
- OJ L 142/248
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
- Version / remarks:
- EPA 712-C-98-247
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- UK Department of Health (inspected on 01 - 03 July 2014 / signed on 16 September 2014)
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- alpha-pinene and beta-pinene dimers
- IUPAC Name:
- alpha-pinene and beta-pinene dimers
- Reference substance name:
- alpha-pinene and beta-pinene trimers
- IUPAC Name:
- alpha-pinene and beta-pinene trimers
- Reference substance name:
- alpha-pinene and beta-pinene tetramers
- IUPAC Name:
- alpha-pinene and beta-pinene tetramers
- Test material form:
- liquid: viscous
- Details on test material:
- Batch No. 14-02 SI
Purity: 100% (UVCB substance)
Name of the test item (as cited in the study report): TERPENIC OLIGOMERS
Physical state: amber viscous liquid
Storage Conditions: +2°C to +8°C, under nitrogen and protected from light
Reassay date: 14 November 2014
Constituent 1
Constituent 2
Constituent 3
Method
- Target gene:
- S. typhimurium: Histidine gene
E. coli: Tryptophan gene
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Details on mammalian cell type (if applicable):
- not applicable
- Additional strain / cell type characteristics:
- not applicable
- Cytokinesis block (if used):
- No
- Metabolic activation:
- with and without
- Metabolic activation system:
- Rat liver S9-mix (Test 1: 10% v/v and Test 2: 20% v/v)
- Test concentrations with justification for top dose:
- First Test: 5, 15, 50, 150, 500, 1500 and 5000 µg/plate
Second test: 50, 150, 500, 1500 and 5000 µg/plate
The highest dose, 5000 µg/plate, is the standard limit concentration recommended in the regulatory guidelines that this assay follows. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: acetone
- Justification for choice of solvent/vehicle: The solubility of Terpenic Oligomers was assessed at 50 mg/mL in water, dimethylsulphoxide (DMSO), acetone and ethanol. It was found to be insoluble in water and DMSO, but dissolved in acetone and ethanol. Acetone (analytical reagent grade) was used as the vehicle for this study.
Controlsopen allclose all
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- sodium azide
- Remarks:
- Without S9 mix, 2 µg/plate in DMSO for strains TA100 and TA1535
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- Remarks:
- Without S9 mix, 50 µg/plate in DMSO for strain TA1537
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 2-nitrofluorene
- Remarks:
- Without S9 mix, 2 µg/plate in DMSO for strain TA98
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- Remarks:
- Without S9 mix, 2 µg/plate in DMSO for strain WP2uvrA (pKM101)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- With S9 mix, 5 µg/plate in DMSO for strains TA100 and TA1535
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: 2-aminoanthracene
- Remarks:
- With S9 mix, 10 µg/plate in DMSO for strain WP2uvrA (pKM101)
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- benzo(a)pyrene
- Remarks:
- With S9 mix, 5 µg/plate in DMSO for strains TA98 and TA1537
- Details on test system and experimental conditions:
- TEST SYSTEM: The strains of S. typhimurium and E. coli were obtained from Moltox Inc. Batches of the strains were stored at ca -80°C as aliquots of nutrient broth cultures. Dimethylsulphoxide (DMSO) was added to the cultures at 8% v/v as a cryopreservative. Each batch of frozen strain was tested for amino acid requirement and, where applicable, for cell membrane permeability (rfa mutation), sensitivity to UV light, and the pKM101 plasmid, which confers resistance to ampicillin. The responses of the strains to a series of reference mutagens were also assessed.
METHOD OF APPLICATION: plate incorporation in agar (two independent tests)
- Cell density at seeding (if applicable): at least 10^9 per mL
DURATION :
- Preincubation period: 10 hours at 37°C with shaking
- Exposure duration: ca. 72 hours at approximately 37°C
NUMBER OF REPLICATIONS: Triplicate plates per dose level.
DETERMINATION OF CYTOTOXICITY
- Method: After this period, the appearance of the background bacterial lawn was examined and revertant colonies counted using an automated colony counter (Perceptive Instruments Sorcerer).
ACCEPTANCE CRITERIA:
For a test to be considered valid:
- The mean of the vehicle control revertant colony numbers for each strain should lie within or close to the current historical control range for the laboratory unless otherwise justified by the Study Director. The historical range is maintained as a rolling record over a maximum of five years.
- Also, the positive control compounds must induce an increase in mean revertant colony numbers of at least twice (three times in the case of strains TA1535 and TA1537, which have relatively low spontaneous reversion rates) that of the concurrent vehicle controls.
- Mean viable cell counts in the 10-hour bacterial cultures must be at least 10^9/mL. - Evaluation criteria:
- - If exposure to a test substance produces a reproducible increase in revertant colony numbers of at least twice (three times in the case of strains TA1535 and TA1537) that of the concurrent vehicle controls, with some evidence of a positive concentration-response relationship, it is considered to exhibit mutagenic activity in this test system.
- If exposure to a test substance does not produce a reproducible increase in revertant colony numbers, it is considered to show no evidence of mutagenic activity in this test system. No statistical analysis is performed.
- If the results obtained fail to satisfy the criteria for a clear “positive” or “negative” response, even after additional testing, the test data may be subjected to analysis to determine the statistical significance of any increases in revertant colony numbers. The statistical procedures used are those described by Mahon et al (1989) and are usually Dunnett’s test followed, if appropriate, by trend analysis. Biological importance will be considered along with statistical significance. In general, treatment-associated increases in revertant colony numbers below two or three times those of the vehicle controls (as described above) are not considered biologically important. It should be noted that it is acceptable to conclude an equivocal response if no clear results can be obtained.
- Occasionally, these criteria may not be appropriate to the test data and, in such cases, the Study Director would use his/her scientific judgement. - Statistics:
- None
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A pKM 101
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity, but tested up to precipitating concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- HISTORICAL CONTROL DATA
- The concurrent positive controls verified the sensitivity of the assay and the metabolising activity of the liver preparations. The mean revertant colony counts for the vehicle controls were within or close to the current historical control range for the laboratory.
ADDITIONAL INFORMATION ON CYTOTOXICITY
- Toxicity (observed as a reduction in revertant colony numbers) was seen in strain TA1537 following exposure to Terpenic Oligomers at 5000 μg/plate in the absence of S9 mix in the second test. No signs of toxicity towards any other tester strains were observed in either mutation test.
- Precipitate was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the presence of S9 mix in both tests and an oily residue was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the absence of S9 mix in both tests.
MUTAGENICITY RESULTS
No evidence of mutagenic activity was seen at any concentration of Terpenic Oligomers in either mutation test. - Remarks on result:
- other: No evidence of mutagenic activity
Any other information on results incl. tables
None
Applicant's summary and conclusion
- Conclusions:
- Terpenic Oligomers did not induce mutation in four histidine-requiring Salmonella typhimurium strains (TA98, TA100, TA1535 and TA1537) and one tryptophan-dependent Escherichia coli strain, WP2 uvrA (pKM101).
- Executive summary:
In a reverse gene mutation assay performed according to OECD Guideline No. 471, EU Method B.13/14, US EPA Health Test Guideline OPPTS 870.5100 and in compliance with GLP, Salmonella typhimurium strains TA1535, TA1537, TA98 and TA100 and Escherichia coli strain WP2uvrA(pKM101) were treated with the test item using the Ames plate incorporation method. Up to seven dose levels were evaluated in triplicate with and without the addition of a rat liver homogenate metabolizing system (10% v/v liver S9 in standard co-factors) in a first test. As a clear negative response was obtained in the first test, a variation to the test procedure was used for the second test. The pre-incubation procedure is not suitable for acetone, which is toxic under such conditions. The variation used was, therefore, an increase in the S9 content of the S9 mix from 10% v/v to 20% v/v. The maximum concentration chosen was again 5000 μg/plate, but only five concentrations were used. These dose levels ranged from 50 to 5000 μg/plate.
Results of the first experiment did not show any evidence of toxicity following exposure to Terpenic Oligomers. Precipitate was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the presence of S9 mix and an oily residue was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the absence of S9 mix. A maximum exposure concentration of 5000 μg/plate was, therefore, selected for use in the second test.
No substantial increases in revertant colony numbers over control counts were obtained with any of the tester strains following exposure to Terpenic Oligomers at any concentration up to and including 5000 μg/plate in either the presence or absence of S9 mix.
After the exposure period of the second experiment, toxicity (observed as a reduction in revertant colony numbers) was seen in strain TA1537 following exposure to Terpenic Oligomers at 5000 μg/plate in the absence of S9 mix. No signs of toxicity towards any other tester strains were observed. Precipitate was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the presence of S9 mix and an oily residue was observed on all plates containing Terpenic Oligomers at 5000 μg/plate in the absence of S9 mix.
No substantial increases in revertant colony numbers over control counts were obtained with any of the tester strains following exposure to Terpenic Oligomers at any concentration up to and including 5000 μg/plate in either the presence or absence of S9 mix.
The concurrent positive controls verified the sensitivity of the assay and the metabolising activity of the liver preparations. The mean revertant colony counts for the vehicle controls were within or close to the current historical control range for the laboratory.
Therefore, Terpenic Oligomers did not induce mutation in four histidine-requiring Salmonella typhimurium strains (TA98, TA100, TA1535 and TA1537) and one tryptophan-dependent Escherichia coli strain, WP2 uvrA (pKM101), when tested at concentrations up to 5000 µg/plate (the maximum recommended concentration according to current regulatory guidelines) in the absence and presence of a rat liver metabolic activation system (S-9).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)